Your browser doesn't support javascript.
Liraglutide as First-Line Therapy for Type 2 Diabetics With Post-COVID-19 Fatigue Syndrome and Executive Function Deficits.
Manu, Peter.
  • Manu P; Department of Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY and Medical Services, South Oaks Hospital, Amityville, NY.
Am J Ther ; 29(5): e568-e569, 2022.
Article in English | MEDLINE | ID: covidwho-2018324
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / COVID-19 / COVID-19 Drug Treatment Topics: Long Covid Limits: Humans Language: English Journal: Am J Ther Journal subject: Therapeutics Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / COVID-19 / COVID-19 Drug Treatment Topics: Long Covid Limits: Humans Language: English Journal: Am J Ther Journal subject: Therapeutics Year: 2022 Document Type: Article